Enzo Biochem settles with Chugai and bioMerieux:
This article was originally published in Clinica
Enzo Biochem has settled a patent dispute with Chugai Pharmaceutical of Japan, which was acquired last year by Roche, and bioMerieux's US arm in Durham, North Carolina. Roche says the dispute will have no financial effect on it, because it concerned the Gen-Probe unit that has now been spun out. Farmingdale, New York-based Enzo's law suit, which relates to its US patent No 4,900,659 covering genetic probes for detecting Neisseria gonorrhoeae, continues with Gen-Probe and another defendant, Becton Dickinson. The terms of the settlement were not disclosed.